The risk of posttraumatic stress disorder after trauma depends on traumatic load and the catechol-o-methyltransferase Val(158)Met polymorphism

Biological Psychiatry
Iris-Tatjana KolassaDominique J-F De Quervain

Abstract

The risk for posttraumatic stress disorder (PTSD) depends on the number of traumatic event types experienced in a dose-response relationship, but genetic factors are known to also influence the risk of PTSD. The catechol-O-methyltransferase (COMT) Val158Met polymorphism has been found to affect fear extinction and might play a role in the etiology of anxiety disorders. Traumatic load and lifetime and current diagnosis of PTSD and COMT genotype were assessed in a sample of 424 survivors of the Rwandan Genocide living in the Nakivale refugee camp in southwestern Uganda. Higher numbers of different lifetime traumatic event types led to a higher prevalence of lifetime PTSD in a dose-response relationship. However, this effect was modulated by the COMT genotype: whereas Val allele carriers showed the typical dose-response relationship, Met/Met homozygotes exhibited a high risk for PTSD independently of the severity of traumatic load. The present findings indicate a gene-environment interaction between the human COMT Val158Met polymorphism and the number of traumatic event types experienced in the risk of developing PTSD.

References

Jan 1, 1974·Behavioral Science·L R DerogatisL Covi
May 20, 1999·Annual Review of Pharmacology and Toxicology·R M WeinshilboumC L Szumlanski
Feb 24, 2001·Medical Decision Making : an International Journal of the Society for Medical Decision Making·E W SteyerbergJ D Habbema
Apr 2, 2002·The American Journal of Psychiatry·Anil K MalhotraDavid Goldman
Apr 21, 2004·Molecular Psychiatry·M A PalmatierK K Kidd
Jun 26, 2004·Annual Review of Neuroscience·James L McGaugh
Aug 12, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Robert M BilderAnthony A Grace
Jan 28, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Michael N SmolkaAndreas Heinz
Jul 5, 2005·The American Journal of Psychiatry·Kenneth S Kendler
Apr 6, 2006·Neuroinformatics·Ke XuDavid Goldman
Jun 23, 2006·Nature Reviews. Neuroscience·Avshalom Caspi, Terrie E Moffitt
Nov 28, 2006·Neuroscience and Biobehavioral Reviews·B F P BroekmanF Boer
Dec 6, 2006·Archives of General Psychiatry·Emily M DrabantDaniel R Weinberger
Apr 10, 2007·European Psychiatry : the Journal of the Association of European Psychiatrists·Ladislav Hosák
Jul 31, 2007·Nature Neuroscience·Dominique J-F de QuervainAndreas Papassotiropoulos
Mar 15, 2008·Biological Psychiatry·Jennifer H BarnettMarcus R Munafò
Apr 17, 2008·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Nicole R NugentKarestan C Koenen
Aug 30, 2008·Behavioral Neuroscience·Christian MontagMartin Reuter
Feb 28, 2009·Social Cognitive and Affective Neuroscience·Oezguer A OnurRené Hurlemann

❮ Previous
Next ❯

Citations

Jun 16, 2010·Current Psychiatry Reports·Marilyn C CornelisKarestan C Koenen
Aug 25, 2012·Clinical Psychology Review·Jessica BomyeaAriel J Lang
Aug 11, 2012·Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies·Ananda B AmstadterKenneth S Kendler
Jan 16, 2013·Molecular Psychiatry·L ZhangR J Ursano
May 16, 2012·Proceedings of the National Academy of Sciences of the United States of America·Dominique J-F de QuervainAndreas Papassotiropoulos
Jan 4, 2013·Biology of Mood & Anxiety Disorders·Julia DigangiKarestan C Koenen
Feb 8, 2013·Biology of Mood & Anxiety Disorders·Kathryn J Lester, Thalia C Eley
May 3, 2011·PloS One·Karen L GambleCarl Hirschie Johnson
May 9, 2014·Psychiatry Research·Jennifer K LenowJosh M Cisler
Feb 11, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Victoria RisbroughXianjin Zhou
Mar 13, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Andrea Hetzel, J Amiel Rosenkranz
Oct 21, 2014·Journal of Child and Adolescent Psychopharmacology·Kathryn L HumphreysStacy S Drury
Feb 9, 2016·Progress in Neuro-psychopharmacology & Biological Psychiatry·Ralph J KoekAndrew Leuchter
May 3, 2015·Contemporary Clinical Trials·Sonya B NormanErika X Blanes
Aug 10, 2011·Journal of Psychiatric Research·Leonardo BaldaçaraRodrigo A Bressan
Mar 2, 2011·Neuropharmacology·Kelly SkeltonBekh Bradley-Davino
Apr 24, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Mark W LogueMonica Uddin
Dec 19, 2013·Neurobiology of Learning and Memory·Megan E TippsK Matthew Lattal
Feb 5, 2016·Neurobiology of Stress·Krista B HighlandMichael J Roy
Apr 22, 2016·Behavioral Medicine·Carlos OsórioIan Robbins
Mar 29, 2011·Psychiatry Research·Joseph A BoscarinoWalter F Stewart
Dec 14, 2011·The International Journal of Neuropsychopharmacology·Diana ArmbrusterClemens Kirschbaum
Oct 10, 2013·The International Journal of Neuropsychopharmacology·Lynn M AlmliKerry J Ressler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.